- Filed
- Nov 13, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Nov 13, 2024 | 30.1M sh |
| Cash And Equivalents | Q1 2025 · Sep 30, 2024 | $2.27M |
| Cash And Equivalents | Q1 2025 · Jun 30, 2024 | $1.68M |
| Current Liabilities | Q1 2025 · Sep 30, 2024 | $6.03M |
| Current Liabilities | Q1 2025 · Jun 30, 2024 | $6.12M |
| Total Liabilities | Q1 2025 · Sep 30, 2024 | $6.63M |
| Total Liabilities | Q1 2025 · Jun 30, 2024 | $6.97M |
| Current Assets | Q1 2025 · Sep 30, 2024 | $18.31M |
| Current Assets | Q1 2025 · Jun 30, 2024 | $17.9M |
| Total Assets | Q1 2025 · Sep 30, 2024 | $26.18M |
| Total Assets | Q1 2025 · Jun 30, 2024 | $26.21M |
| Total Assets restated | Q1 2025 · Jun 30, 2023 | $26.21M |
| Shares Diluted | Q1 2025 · Sep 30, 2023 | 29.97M sh |
| Capex | Q1 2025 · Sep 30, 2023 | $38K |
| Operating Cash Flow | Q1 2025 · Sep 30, 2023 | $1.31M |
| Stockholders Equity | Q1 2025 · Sep 30, 2023 | $18.89M |
| Stockholders Equity | Q1 2025 · Jun 30, 2023 | $18.86M |
| Eps Diluted | Q1 2025 · Sep 30, 2023 | $0.00 |
| Eps Basic | Q1 2025 · Sep 30, 2023 | $0.00 |
| Sga Expense | Q1 2025 · Sep 30, 2023 | $886K |
| Net Income | Q1 2025 · Sep 30, 2023 | −$59K |
| Operating Income | Q1 2025 · Sep 30, 2023 | −$54K |
| Gross Profit | Q1 2025 · Sep 30, 2023 | $832K |
| Cost Of Revenue | Q1 2025 · Sep 30, 2023 | $12.08M |